Frontlight ResearchEarly access
Trial site
Copenhagen
- 3running trials
- 6closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease2 trials
- Lung cancer2 trials
- Stroke2 trials
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Hidradenitis suppurativa1 trial
- Multiple sclerosis1 trial
- Myeloproliferative neoplasms1 trial
- Spinal muscular atrophy1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 1/22 trials
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Active, not recruiting
Active, not recruiting
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Active, not recruiting
Closed trials
Completed
Completed
Terminated
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026